Deutsche Bank’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-98,700
| Closed | -$1.88M | – | 5743 |
|
|
2019
Q1 | $1.88M | Buy |
98,700
+97,200
| +6,480% | +$1.58M | ﹤0.01% | 2556 |
|
|
2018
Q4 | $20K | Sell |
1,500
-24,640
| -94% | -$275K | ﹤0.01% | 4745 |
|
|
2018
Q3 | $290K | Buy |
+26,140
| New | +$262K | ﹤0.01% | 4067 |
|
|
2017
Q1 | – | Sell |
-202,699
| Closed | -$993K | – | 5364 |
|
|
2016
Q4 | $993K | Buy |
202,699
+130,635
| +181% | +$669K | ﹤0.01% | 2706 |
|
|
2016
Q3 | $356K | Sell |
72,064
-70,521
| -49% | -$361K | ﹤0.01% | 3361 |
|
|
2016
Q2 | $724K | Buy |
142,585
+123,726
| +656% | +$666K | ﹤0.01% | 3077 |
|
|
2016
Q1 | $106K | Sell |
18,859
-26,864
| -59% | -$188K | ﹤0.01% | 3983 |
|
|
2015
Q4 | $472K | Buy |
45,723
+34,759
| +317% | +$472K | ﹤0.01% | 3305 |
|
|
2015
Q3 | $202K | Sell |
10,964
-12,912
| -54% | -$249K | ﹤0.01% | 3794 |
|
|
2015
Q2 | $463K | Buy |
23,876
+15,538
| +186% | +$275K | ﹤0.01% | 3442 |
|
|
2015
Q1 | $144K | Buy |
8,338
+832
| +11% | +$14K | ﹤0.01% | 3965 |
|
|
2014
Q4 | $119K | Sell |
7,506
-4,157
| -36% | -$55.7K | ﹤0.01% | 4612 |
|
|
2014
Q3 | $146K | Buy |
11,663
+4,973
| +74% | +$70.9K | ﹤0.01% | 4268 |
|
|
2014
Q2 | $104K | Sell |
6,690
-7,779
| -54% | -$114K | ﹤0.01% | 4547 |
|
|
2014
Q1 | $189K | Buy |
14,469
+2,129
| +17% | +$33.3K | ﹤0.01% | 3924 |
|
|
2013
Q4 | $198K | Sell |
12,340
-13,148
| -52% | -$210K | ﹤0.01% | 3706 |
|
|
2013
Q3 | $423K | Buy |
25,488
+4,584
| +22% | +$67.8K | ﹤0.01% | 3631 |
|
|
2013
Q2 | $209K | Buy |
+20,904
| New | +$220K | ﹤0.01% | 3795 |
|
Other funds holding OSIR
Deutsche Bank's OSIR Position: Q2 2019 in Review
Deutsche Bank sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 98,700 shares — an estimated $1.88M sold.
Deutsche Bank first reported a position in OSIR in Q2 2013 and held it in 18 quarters. The position peaked at $1.88M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.
- Deutsche Bank reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
- Deutsche Bank sold 98,700 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.88M.
- Deutsche Bank first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 18 quarters.
- Deutsche Bank's Osiris Therapeutics, Inc. Common Stock position peaked at $1.88M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.
Based on Deutsche Bank's 13F filing for Q2 2019, filed 14 Aug 2019.